The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Open accessAbstract
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary malignancy in the liver. ICC has been classified as a malignant tumor arising from cholangiocytes; however, the co-occurrence of ICC and viral hepatitis suggests that ICC originates in hepatocytes. In order to determine the cellular origin of ICC, we used a mouse model of ICC in which hepatocytes and cholangiocytes were labeled with heritable, cell type–specific reporters. Our studies reveal that ICC is generated by biliary lineage cells derived from hepatocytes, rather than cholangiocytes. Additionally, we found that Notch activation is critical for hepatocyte conversion into biliary lineage cells during the onset of ICC and its subsequent malignancy and progression. These findings will help to elucidate the pathogenic mechanism of ICC and to develop therapeutic strategies for this refractory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Notch signaling controls multiple steps of pancreatic differentiation
Murtaugh, L. C., Stanger, B. Z., Kwan, K. M., & Melton, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436557100 · Cited by 782
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
A mouse model of Alagille syndrome:Notch2 as a genetic modifier of Jag1 haploinsufficiency
McCright, B., Lozier, J., & Gridley, T. (2002) · Development · doi:10.1242/dev.129.4.1075 · Cited by 487
Notch signaling controls liver development by regulating biliary differentiation
Zong, Y., Panikkar, A., Xu, J., Antoniou, A., Raynaud, P., Lemaigre, F., & Stanger, B. Z. (2009) · Development · doi:10.1242/dev.029140 · Cited by 444
Michalopoulos, G. K., Barua, L., & Bowen, W. C. (2005) · Hepatology · doi:10.1002/hep.20600 · Cited by 319 · cited 1×
“In the portal areas of the hepatic lobule, it has been reported that hepatocytes can change into biliary lineage cells when intrahepatic bile duct regeneration is induced, but cholan-giocytes cannot proliferate owing to toxic influences (17).”
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver
de Boer, C. J., van Krieken, J. H. J. M., Janssen-van Rhijn, C. M., & Litvinov, S. V. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2<201::aid-path339>3.0.co;2-8 · Cited by 236
Goodman, Z. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800682 · Cited by 217
Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system.
Hunter, A. L., Holscher, M. A., & Neal, R. A. (1977) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30789-5 · Cited by 194
Imayoshi, I., Shimogori, T., Ohtsuka, T., & Kageyama, R. (2008) · Development · doi:10.1242/dev.021535 · Cited by 194
Cholangiocarcinoma: Update and future perspectives
Gatto, M., Bragazzi, M. C., Semeraro, R., Napoli, C., Gentile, R., Torrice, A., Gaudio, E., & Alvaro, D. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.12.008 · Cited by 188
Intrahepatic Cholangiocarcinoma: New Insights in Pathology
Sempoux, C., Jibara, G., Ward, S., Fan, C., Qin, L., Roayaie, S., Fiel, M. I., Schwartz, M., & Thung, S. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1272839 · Cited by 186
Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse
Schuler, M., Dierich, A., Chambon, P., & Metzger, D. (2004) · genesis · doi:10.1002/gene.20039 · Cited by 174
Lee, C. H., Chang, C. J., Lin, Y.-H., Yeh, C.-N., Chen, M. F., & Hsieh, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605063 · Cited by 138
Anundi, I., Lähteenmäki, T., Rundgren, M., Moldeus, P., & Lindros, K. O. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90277-4 · Cited by 120
Mansuroglu, T., Ramadori, P., Dudás, J., Malik, I. A., Hammerich, K., FÜZESI, L., & Ramadori, G. P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.15 · Cited by 55
Growth hormone mediates zone‐specific gene expression in liver
Oinonen, T., Nikkola, E., & Lindros, K. O. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80176-u · Cited by 27
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Metadata
- Authors
- Sekiya, S., & Suzuki, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 11
- Pages
- 3914-3918
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2138908889
- Cited by
- 348
- References
- 19
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.